ARTICLE | Clinical News
Renagel non-absorbed phosphate binder regulatory update
February 7, 2000 8:00 AM UTC
The partners received EU marketing approval for Renagel to control hyperphosphatemia in patients on dialysis. The product, which also is approved in the U.S. and Israel, is marketed by a joint venture...